DalsnaFinance

Oscar Health Inc Class a $OSCR

Financials

Russell 2000 New York
Create a scorecard
$33.32
-0.13 (-0.39%)
As of Oct 22, 2026, 9:33 PM EDT
Price history
Loading chart…

Oscar Health Inc Class a (OSCR) is trading down at $33.32 (-0.39%), as of the latest quote. It is a Russell 2000 constituent in the Financials sector.

IPO: March 3, 2021 · $39.00 offering · NYSE · View IPO details →

Oscar Health Inc Class a revenue & net income history (FY2019–FY2025)

RevenueNet incomeNet margin (right axis, %)
$11.7B$5.55B−$606.3MFY2019 revenue: $488.2MFY2019 net income: −$261.2M · Net margin −53.5%'19FY2020 revenue: $462.8MFY2020 net income: −$406.8M · Net margin −87.9%'20FY2021 revenue: $1.84BFY2021 net income: −$572.6M · Net margin −31.1%'21FY2022 revenue: $3.96BFY2022 net income: −$606.3M · Net margin −15.3%'22FY2023 revenue: $5.86BFY2023 net income: −$270.7M · Net margin −4.6%'23FY2024 revenue: $9.18BFY2024 net income: $25.4M · Net margin 0.3%'24FY2025 revenue: $11.7BFY2025 net income: −$443.2M · Net margin −3.8%'250%5%10%15%20%FY2019 net margin: −53.5% (off the scale, which stops at −1.0%)FY2020 net margin: −87.9% (off the scale, which stops at −1.0%)FY2021 net margin: −31.1% (off the scale, which stops at −1.0%)FY2022 net margin: −15.3% (off the scale, which stops at −1.0%)FY2023 net margin: −4.6% (off the scale, which stops at −1.0%)FY2024 net margin: 0.3%FY2025 net margin: −3.8% (off the scale, which stops at −1.0%)
Oscar Health Inc Class a annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$488.2M$462.8M$1.84B$3.96B$5.86B$9.18B$11.7B
Growth (year over year)—−5.2%+297.3%+115.6%+47.9%+56.5%+27.5%
Operating income−$259.4M−$402.3M−$544.5M−$589.9M−$235.6M$57.3M−$396.4M
Operating margin−53.1%−86.9%−29.6%−14.9%−4.0%0.6%−3.4%
Net income−$261.2M−$406.8M−$572.6M−$606.3M−$270.7M$25.4M−$443.2M
Net margin−53.5%−87.9%−31.1%−15.3%−4.6%0.3%−3.8%
EPS (diluted)−$9.06−$14.16−$3.20−$2.85−$1.22$0.10−$1.69
Balance sheet
Cash and equivalents$336.6M$826.3M$1.10B$1.56B$1.87B$1.53B$2.77B
Total assets—$2.27B$3.32B$4.53B$3.60B$4.84B$6.33B
Total liabilities—$1.82B$1.93B$3.63B$2.80B$3.82B$5.34B
Long-term debt—$142.5M$0$298.0M$298.8M$299.6M$430.1M
Shareholders' equity−$945.1M−$1.30B$1.39B$890.4M$804.0M$1.01B$977.6M
Cash flow
Operating cash flow−$165.4M$222.7M−$181.7M$380.3M−$272.2M$978.2M$1.09B
Capital expenditure$26.0M$14.0M$25.9M$29.0M$25.6M$27.9M$36.4M
Free cash flow−$191.4M$208.7M−$207.6M$351.3M−$297.7M$950.3M$1.06B
Share buybacks$2.99M$0$0————

From Oscar Health Inc Class a's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Oscar Health Inc Class a

Headquarters
New York, New York From SEC filings, Oct 2026

Recent News (1)

More Financials stocks

Browse all companies →